1-3 of 3
Hamood Alqahtani, MBBS
Close
Sort by
Journal Articles

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI) Predicts Survival and Tolerance of Ibrutinib Therapy in Patients with CLL: A Multicenter Retrospective Cohort Study

Max J. Gordon, MD, Andy Kaempf, MS, Andrea Sitlinger, MD, Tareq Salous, Hamood Alqahtani, MBBS, Michael C. Churnetski, Paul Wisniewski, BS, Xavier Issac Rivera, BS, Krish Patel, MD, Daniel O. Persky, MD, Jonathon B. Cohen, MDMS, Michael Y. Choi, MD, Brian T. Hill, MD, Mazyar Shadman, MDMPH, Deborah M. Stephens, DO, Danielle M. Brander, MD, Byung Park, PhD, Alexey Danilov, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-136808
Published: 2020
Journal Articles

The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Novel Comorbidity Score Derived from a Large Multicenter Retrospective Cohort Study of Patients Treated with Ibrutinib and/or Chemo-Immunotherapy (CIT)

Max J. Gordon, MD, Andy Kaempf, Andrea Sitlinger, MD, Tareq Salous, Hamood Alqahtani, MBBS, Michael C. Churnetski, Paul Wisniewski, Xavier Issac Rivera, BS, Krish Patel, MD, Daniel O. Persky, MD, Jonathon B. Cohen, MDMS, Michael Y. Choi, MD, Brian T. Hill, MD, Mazyar Shadman, MD, Deborah M. Stephens, DO, Danielle M. Brander, MD, Byung Park, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4286.
https://doi.org/10.1182/blood-2019-124631
Published: 2019
Journal Articles

Impact of Individual Comorbidities on Treatment Outcomes in Chronic Lymphocytic Leukemia

Max J. Gordon, MD, Michael C Churnetski, BS, Hamood Alqahtani, MBBS, Xavier Issac Rivera, BS, Adam Kittai, MD, Nur Bruss, BS, Sheila Hoff, BSN, Michael Y. Choi, MD, Jonathon B. Cohen, MD MS, Daniel Persky, MD, Byung Park, PhD, Alexey V Danilov, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4848.
https://doi.org/10.1182/blood-2018-99-113917
Published: 2018